Hepatitis Acute Fulminant and Thyrotosicosis

Detalhes bibliográficos
Autor(a) principal: Miranda, Carla Paixão
Data de Publicação: 2017
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Científica da Faculdade de Medicina de Campos
Texto Completo: https://www.fmc.br/ojs/index.php/RCFMC/article/view/37
Resumo: Herein, we present the case of a female patient, 44 years old, who was transferred to the intensive care center (ICU) of the Hospital das Clínicas in Belo Horizonte/MG, with abdominal pain, nausea, vomiting, jaundice and fever, anorexia, loss of appetite, whose symptoms began 30 days ago. She has a history of hypothyroidism being treated irregularly with T4 for the last five years and stopped the treatment when the current symptoms appeared. She presented T3 (7.26 pg/mL) VN: 2.77 to 5.07; TSH (0.214 IU/mL) VN: 0.465. Transaminases AST (977 U/L) VN: 15 to 46; ALT (795 U/L) VN:13 to 69; bilirubin total (4.12 mg/dL) VN: 0.2 to 1.3; direct bilirubin (30 mg/dL) VN: up to 0.25. She was maintained without anti-thyroid and was started on propranolol at a dosage of up to 480 mg/day. An MRI abdominal exam presented cholangiocarcinoma with free abdominal fluid, suggestive of being related to the inflammatory process. There was non-specific thickening of the gallbladder and bilateral pleural effusion. The serology exam for Hepatitis A, B, and C was negative. There was liver function deterioration and high levels of thyroid hormones were maintained. The patient suffered an acute fulminant hepatic failure and was immediately submitted to a hepatic transplant.  After the procedure the liver (explant) was sent for anatomopathological study; histopathologic findings included the presence of an extensive area of necrosis of the liver parenchyma. The remaining septa showed mononuclear inflammatory infiltrates (MNII). Therefore, it was concluded that chronic hyperthyroidism can exacerbate and perpetuate acute fulminant hepatic failur and that regular medicinal treatment, together with clinically routine laboratory exames could prevent serious complications, permitting successful therapy in patients with hyperthyroidism.
id FMC-0_ab17ee27cef7a29c3273ff9c0acabae2
oai_identifier_str oai:ojs.www.fmc.br:article/37
network_acronym_str FMC-0
network_name_str Revista Científica da Faculdade de Medicina de Campos
repository_id_str
spelling Hepatitis Acute Fulminant and ThyrotosicosisHEPATITE AGUDA FULMINANTE E TIREOTOXICOSETireoideHepatiteFígadoInflamaçãoTireotoxicoseInflammationThyroidLiverThyrotoxicosisHepatitisHerein, we present the case of a female patient, 44 years old, who was transferred to the intensive care center (ICU) of the Hospital das Clínicas in Belo Horizonte/MG, with abdominal pain, nausea, vomiting, jaundice and fever, anorexia, loss of appetite, whose symptoms began 30 days ago. She has a history of hypothyroidism being treated irregularly with T4 for the last five years and stopped the treatment when the current symptoms appeared. She presented T3 (7.26 pg/mL) VN: 2.77 to 5.07; TSH (0.214 IU/mL) VN: 0.465. Transaminases AST (977 U/L) VN: 15 to 46; ALT (795 U/L) VN:13 to 69; bilirubin total (4.12 mg/dL) VN: 0.2 to 1.3; direct bilirubin (30 mg/dL) VN: up to 0.25. She was maintained without anti-thyroid and was started on propranolol at a dosage of up to 480 mg/day. An MRI abdominal exam presented cholangiocarcinoma with free abdominal fluid, suggestive of being related to the inflammatory process. There was non-specific thickening of the gallbladder and bilateral pleural effusion. The serology exam for Hepatitis A, B, and C was negative. There was liver function deterioration and high levels of thyroid hormones were maintained. The patient suffered an acute fulminant hepatic failure and was immediately submitted to a hepatic transplant.  After the procedure the liver (explant) was sent for anatomopathological study; histopathologic findings included the presence of an extensive area of necrosis of the liver parenchyma. The remaining septa showed mononuclear inflammatory infiltrates (MNII). Therefore, it was concluded that chronic hyperthyroidism can exacerbate and perpetuate acute fulminant hepatic failur and that regular medicinal treatment, together with clinically routine laboratory exames could prevent serious complications, permitting successful therapy in patients with hyperthyroidism.Paciente feminino, 44 anos transferida para o centro de terapia intensiva (CTI) do Hospital das Clínicas de Belo Horizonte/MG, com quadro de dor abdominal, náuseas, vômitos, icterícia e febre, anorexia, inapetência, iniciado há 30 dias. História de hipotireoidismo e tratamento irregular com T4 há cinco anos; interrompeu a medicação quando iniciou o quadro atual. Apresentava T3 (7,26 pg/ml) VN.: 2,77 a 5,07; TSH (0,214 mU/L) VN: 0,465. Transaminases AST (977  U/L) VN.:15 a 46; ALT (795 U/L) VN.:13 a 69; bilirrubina total (4.12 mg/dL) VN.: 0.2 a 1.3; bilirrubina direta (30 mg/dL) VN.: até 0.25. Foi mantida sem anti- tireoidiano e iniciado propranolol até dose de 480 mg /dia. Exame de ressonância magnética abdominal e colangio com líquido livre abdominal, sugestivo de estar relacionado ao processo inflamatório. Espessamento inespecífico da vesícula biliar. Derrame pleural bilateral. Sorologia para o vírus da hepatite A, B e C negativo. Ocorreu piora da função hepática e manutenção de níveis elevados de hormônios tireoidianos. A paciente evoluiu para um quadro de hepatite aguda fulminante, imediatamente submetida ao transplante hepático. Após procedimento o fígado (explante) foi enviado para estudo anatopatológico; os achados histopatológicos incluíram a presença de extensa área de necrose do parênquima hepático. Nos septos remanescentes, mostravam-se infiltrados inflamatórios mononucleares (IIMM). Conclui-se, portanto, que o hipertireoidismo crônico pode exacerbar e perpetuar a disfunção hepática aguda fulminante e que o tratamento medicamentoso regular aliado aos exames laboratoriais de rotina clínica poderão prevenir complicações graves, permitindo uma terapêutica bem sucedida em pacientes com hipertireoidismo.Faculdade de Medicina de Campos (FMC)2017-07-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/3710.29184/1980-7813.rcfmc.37.vol.12.n1.2017Scientific Journal of the Medical School of Campos; Vol. 12 No. 1 (2017); 26-32Revista Científica da Faculdade de Medicina de Campos; v. 12 n. 1 (2017); 26-321980-7813reponame:Revista Científica da Faculdade de Medicina de Camposinstname:Faculdade de Medicina de Campos (FMC)instacron:FMCporhttps://www.fmc.br/ojs/index.php/RCFMC/article/view/37/139Copyright (c) 2017 Revista Científica da Faculdade de Medicina de Camposinfo:eu-repo/semantics/openAccessMiranda, Carla Paixão2017-12-12T17:30:29Zoai:ojs.www.fmc.br:article/37Revistahttps://www.fmc.br/ojs/index.php/RCFMC/PRIhttps://www.fmc.br/ojs/index.php/RCFMC/oai||revista@fmc.br1980-78131980-7813opendoar:2017-12-12T17:30:29Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)false
dc.title.none.fl_str_mv Hepatitis Acute Fulminant and Thyrotosicosis
HEPATITE AGUDA FULMINANTE E TIREOTOXICOSE
title Hepatitis Acute Fulminant and Thyrotosicosis
spellingShingle Hepatitis Acute Fulminant and Thyrotosicosis
Miranda, Carla Paixão
Tireoide
Hepatite
Fígado
Inflamação
Tireotoxicose
Inflammation
Thyroid
Liver
Thyrotoxicosis
Hepatitis
title_short Hepatitis Acute Fulminant and Thyrotosicosis
title_full Hepatitis Acute Fulminant and Thyrotosicosis
title_fullStr Hepatitis Acute Fulminant and Thyrotosicosis
title_full_unstemmed Hepatitis Acute Fulminant and Thyrotosicosis
title_sort Hepatitis Acute Fulminant and Thyrotosicosis
author Miranda, Carla Paixão
author_facet Miranda, Carla Paixão
author_role author
dc.contributor.author.fl_str_mv Miranda, Carla Paixão
dc.subject.por.fl_str_mv Tireoide
Hepatite
Fígado
Inflamação
Tireotoxicose
Inflammation
Thyroid
Liver
Thyrotoxicosis
Hepatitis
topic Tireoide
Hepatite
Fígado
Inflamação
Tireotoxicose
Inflammation
Thyroid
Liver
Thyrotoxicosis
Hepatitis
description Herein, we present the case of a female patient, 44 years old, who was transferred to the intensive care center (ICU) of the Hospital das Clínicas in Belo Horizonte/MG, with abdominal pain, nausea, vomiting, jaundice and fever, anorexia, loss of appetite, whose symptoms began 30 days ago. She has a history of hypothyroidism being treated irregularly with T4 for the last five years and stopped the treatment when the current symptoms appeared. She presented T3 (7.26 pg/mL) VN: 2.77 to 5.07; TSH (0.214 IU/mL) VN: 0.465. Transaminases AST (977 U/L) VN: 15 to 46; ALT (795 U/L) VN:13 to 69; bilirubin total (4.12 mg/dL) VN: 0.2 to 1.3; direct bilirubin (30 mg/dL) VN: up to 0.25. She was maintained without anti-thyroid and was started on propranolol at a dosage of up to 480 mg/day. An MRI abdominal exam presented cholangiocarcinoma with free abdominal fluid, suggestive of being related to the inflammatory process. There was non-specific thickening of the gallbladder and bilateral pleural effusion. The serology exam for Hepatitis A, B, and C was negative. There was liver function deterioration and high levels of thyroid hormones were maintained. The patient suffered an acute fulminant hepatic failure and was immediately submitted to a hepatic transplant.  After the procedure the liver (explant) was sent for anatomopathological study; histopathologic findings included the presence of an extensive area of necrosis of the liver parenchyma. The remaining septa showed mononuclear inflammatory infiltrates (MNII). Therefore, it was concluded that chronic hyperthyroidism can exacerbate and perpetuate acute fulminant hepatic failur and that regular medicinal treatment, together with clinically routine laboratory exames could prevent serious complications, permitting successful therapy in patients with hyperthyroidism.
publishDate 2017
dc.date.none.fl_str_mv 2017-07-31
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.fmc.br/ojs/index.php/RCFMC/article/view/37
10.29184/1980-7813.rcfmc.37.vol.12.n1.2017
url https://www.fmc.br/ojs/index.php/RCFMC/article/view/37
identifier_str_mv 10.29184/1980-7813.rcfmc.37.vol.12.n1.2017
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.fmc.br/ojs/index.php/RCFMC/article/view/37/139
dc.rights.driver.fl_str_mv Copyright (c) 2017 Revista Científica da Faculdade de Medicina de Campos
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2017 Revista Científica da Faculdade de Medicina de Campos
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina de Campos (FMC)
publisher.none.fl_str_mv Faculdade de Medicina de Campos (FMC)
dc.source.none.fl_str_mv Scientific Journal of the Medical School of Campos; Vol. 12 No. 1 (2017); 26-32
Revista Científica da Faculdade de Medicina de Campos; v. 12 n. 1 (2017); 26-32
1980-7813
reponame:Revista Científica da Faculdade de Medicina de Campos
instname:Faculdade de Medicina de Campos (FMC)
instacron:FMC
instname_str Faculdade de Medicina de Campos (FMC)
instacron_str FMC
institution FMC
reponame_str Revista Científica da Faculdade de Medicina de Campos
collection Revista Científica da Faculdade de Medicina de Campos
repository.name.fl_str_mv Revista Científica da Faculdade de Medicina de Campos - Faculdade de Medicina de Campos (FMC)
repository.mail.fl_str_mv ||revista@fmc.br
_version_ 1798042300982493184